A mobile health intervention to improve sleep in adolescents
Reducing Risk: A Comprehensive mHealth Sleep Health Intervention for Adolescents at Risk for Depression and Anxiety Disorders
This study is testing a new mobile app designed to help teenagers with sleep problems feel better and improve their mental health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT03665337 on ClinicalTrials.gov |
What this trial studies
This study tests a mobile health adaptation of a behavioral intervention aimed at improving sleep and mental health among adolescents suffering from insomnia and delayed sleep phase. Participants will be assigned to either the mTranS-C intervention or a control group to evaluate the effectiveness of the mobile health approach. The study focuses on utilizing technology to enhance behavioral strategies for better sleep outcomes. By engaging adolescents through a mobile platform, the study aims to provide a more accessible and effective solution for sleep-related issues.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents experiencing insomnia or delayed sleep phase.
Not a fit: Patients with current psychiatric illnesses or those on medications affecting sleep may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve sleep quality and mental health in adolescents.
How similar studies have performed: Other studies have shown promise in using mobile health interventions for behavioral health, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Exclusion Criteria: * any current psychiatric illness * currently use of medications or herbs with known effects on sleep * hospitalization for substance use or suicide within the past 12 months * known sleep apnea * unstable major medical conditions * current psychotherapy for depression, anxiety or sleep health deficits
Where this trial is running
San Francisco, California
- University of California, San Francisco — San Francisco, California, United States (Recruiting)
Study contacts
- Principal investigator: Lauren Asarnow, PhD — University of California, San Francisco
- Study coordinator: Lauren Asarnow, PhD
- Email: Lauren.Asarnow@ucsf.edu
- Phone: (415) 476-7439
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.